当前位置: X-MOL 学术Nat. Neurosci. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Multi-omic analysis of selectively vulnerable motor neuron subtypes implicates altered lipid metabolism in ALS
Nature Neuroscience ( IF 21.2 ) Pub Date : 2021-11-15 , DOI: 10.1038/s41593-021-00944-z
Hojae Lee 1, 2, 3 , Jae Jin Lee 4 , Na Young Park 5, 6 , Sandeep Kumar Dubey 2, 7 , Taeyong Kim 8 , Kai Ruan 2 , Su Bin Lim 9 , Seong-Hyun Park 1, 2 , Shinwon Ha 1, 2 , Irina Kovlyagina 1, 10 , Kyung-Tai Kim 11, 12 , Seongjun Kim 1 , Yohan Oh 1, 13 , Hyesoo Kim 1, 2 , Sung-Ung Kang 1, 2 , Mi-Ryoung Song 11 , Thomas E Lloyd 2, 7, 14 , Nicholas J Maragakis 2 , Young Bin Hong 5, 6 , Hyungjin Eoh 4 , Gabsang Lee 1, 2, 3, 7
Affiliation  

Amyotrophic lateral sclerosis (ALS) is a devastating disorder in which motor neurons degenerate, the causes of which remain unclear. In particular, the basis for selective vulnerability of spinal motor neurons (sMNs) and resistance of ocular motor neurons to degeneration in ALS has yet to be elucidated. Here, we applied comparative multi-omics analysis of human induced pluripotent stem cell-derived sMNs and ocular motor neurons to identify shared metabolic perturbations in inherited and sporadic ALS sMNs, revealing dysregulation in lipid metabolism and its related genes. Targeted metabolomics studies confirmed such findings in sMNs of 17 ALS (SOD1, C9ORF72, TDP43 (TARDBP) and sporadic) human induced pluripotent stem cell lines, identifying elevated levels of arachidonic acid. Pharmacological reduction of arachidonic acid levels was sufficient to reverse ALS-related phenotypes in both human sMNs and in vivo in Drosophila and SOD1G93A mouse models. Collectively, these findings pinpoint a catalytic step of lipid metabolism as a potential therapeutic target for ALS.

更新日期:2021-11-15
down
wechat
bug